Short Interest in Option Care Health, Inc. (NASDAQ:OPCH) Drops By 34.8%

Option Care Health, Inc. (NASDAQ:OPCH) was the target of a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 3,800,000 shares, a decline of 34.8% from the December 31st total of 5,830,000 shares. Currently, 2.3% of the company’s shares are short sold. Based on an average daily trading volume, of 2,120,000 shares, the short-interest ratio is currently 1.8 days.

Analysts Set New Price Targets

Several brokerages have recently weighed in on OPCH. Truist Financial dropped their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities reiterated a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Barrington Research upped their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a report on Tuesday, January 14th. Finally, UBS Group began coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $32.25.

Option Care Health Trading Down 1.9 %

NASDAQ:OPCH opened at $30.83 on Wednesday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a 50-day moving average of $24.62 and a 200-day moving average of $27.85. The company has a market cap of $5.25 billion, a PE ratio of 25.91, a PEG ratio of 2.11 and a beta of 1.31. Option Care Health has a one year low of $21.39 and a one year high of $34.63.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.64% of the stock is owned by company insiders.

Institutional Investors Weigh In On Option Care Health

Institutional investors have recently added to or reduced their stakes in the company. Westfield Capital Management Co. LP grew its position in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after purchasing an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. grew its position in Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock worth $1,559,000 after purchasing an additional 25,905 shares in the last quarter. Graypoint LLC bought a new stake in Option Care Health in the 4th quarter worth about $1,161,000. Victory Capital Management Inc. grew its position in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after purchasing an additional 1,585,818 shares in the last quarter. Finally, Barclays PLC grew its position in Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock worth $9,708,000 after purchasing an additional 199,454 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.